About this trial
Depression and anxiety affects levels of function across different levels like work, increasing levels of sick leave and as well as cognitive functioning. In the current study patients at risk of sick leave with depression and anxiety receive metacognitive therapy and work focus in an ordinary outpatient clinic. Impaired cognitive functioning may also be of importance in the return to work process and degree of sick leave. It is important to get a better understanding of how cognitive functioning is related to sick leave and if it predicts return to work, and if cognitive functioning is changed due to psychological treatment.
Eligibility criteria
Qualifiers
diagnosis of depression and/or anxiety,
at risk of sick leave
Disqualifiers
personality disorders cluster A or B,
ongoing substance abuse,
symptoms of psychosis,
acute suicidality,
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Norwegian University of Science and Technology
Lead sponsor
Diakonhjemmet Hospital
Collaborator
The Research Council of Norway
Collaborator